• 2004

Company Description

Biosystems International is a biotechnology company engaged in the development of blood-based diagnostics for cancer and chronic diseases.

BioSystems International (BSI) brings biomarkers to the bedside. They improve pharmaceutical drug discovery and development productivity, i.e. safer and more effective drugs at lower costs and in less time. BSI delivers tools for disease management.